Ocumension Therapeutics

Director at EYPT

Sold, on record
$56.7M
Dollars the filings state
Form 4 sales
2
Latest Jan 11, 2024
Form 144 notices
3
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • EYPTEyePoint, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice EYPTNotice
    May 26, 2023 2023

    Filed to sell 3M shares ($17.9M)

    Ocumension Therapeutics, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice EYPTNotice
    Dec 5, 2023 +193 days

    Filed to sell 1M shares ($18.3M)

    Ocumension Therapeutics, Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale EYPTUnusual
    Dec 6, 2023 +1 day

    Sold 1M shares at $19.51 ($19.5M)

    Ocumension Therapeutics, Director

    No 10b5-1 planSold 33.2% of holdings ($58.7M position)2M shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 144 notice EYPTNotice
    Jan 11, 2024 +36 days

    Filed to sell 1.9M shares ($37.2M)

    Ocumension Therapeutics, Director

    No 10b5-1 planFiling

  5. 5 Form 4 sale EYPTUnusual
    Jan 11, 2024 same day

    Sold 1.9M shares at $19.45 ($37.2M)

    Ocumension Therapeutics, Director

    No 10b5-1 planSold 95% of holdings ($39.1M position)100,221 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Ocumension Therapeutics
Source
Jan 11, 2024Jan 16, 2024EYPTDirectorForm 4 sale1.9M$37.2M95.0%UnusualSEC
Jan 11, 2024Jan 11, 2024EYPTDirectorForm 144 notice1.9M$37.2MNoticeSEC
Dec 6, 2023Dec 7, 2023EYPTDirectorForm 4 sale1M$19.5M33.2%UnusualSEC
Dec 5, 2023Dec 5, 2023EYPTDirectorForm 144 notice1M$18.3MNoticeSEC
May 26, 2023May 26, 2023EYPTDirectorForm 144 notice3M$17.9MNoticeSEC